[HTML][HTML] A five-gene signature and clinical outcome in non–small-cell lung cancer
Background Current staging methods are inadequate for predicting the outcome of treatment
of non–small-cell lung cancer (NSCLC). We developed a five-gene signature that is closely …
of non–small-cell lung cancer (NSCLC). We developed a five-gene signature that is closely …
Association of patient characteristics and tumor genomics with clinical outcomes among patients with non–small cell lung cancer using a clinicogenomic database
… Importance Data sets linking comprehensive genomic profiling (CGP) to clinical outcomes
… clinical data with CGP can identify and extend associations in non–small cell lung cancer (…
… clinical data with CGP can identify and extend associations in non–small cell lung cancer (…
Clinical outcomes in non‐small‐cell lung cancer patients with EGFR mutations: pooled analysis
L Paz‐Ares, D Soulières, I Melezínek… - Journal of cellular …, 2010 - Wiley Online Library
… Non-small-cell lung cancer (NSCLC) with mutations in the epidermal growth factor receptor
(… A weighted pooled analysis of available studies was performed to evaluate clinical outcome …
(… A weighted pooled analysis of available studies was performed to evaluate clinical outcome …
Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status
A Kalikaki, A Koutsopoulos, D Hatzidaki, M Trypaki… - Lung cancer, 2010 - Elsevier
… Whether EGFR and K-RAS mutations could also predict clinical outcome of non-small cell
lung cancer (NSCLC) patients following front-line chemotherapy has not yet been established. …
lung cancer (NSCLC) patients following front-line chemotherapy has not yet been established. …
[HTML][HTML] Peripheral blood biomarkers associated with clinical outcome in non–small cell lung cancer patients treated with nivolumab
J Tanizaki, K Haratani, H Hayashi, Y Chiba… - Journal of thoracic …, 2018 - Elsevier
… clinical outcome in patients with lung with cancer treated with ICIs. We have now examined
the possible impact of clinical … setting—including peripheral blood cell counts such as ANC, …
the possible impact of clinical … setting—including peripheral blood cell counts such as ANC, …
Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome
JB Prévost, MS Hoogeman, J Praag… - Radiotherapy and …, 2009 - Elsevier
… the clinical outcome of treatment using real-time tumor tracking … with inoperable stage I
non-small cell lung cancer (NSCLC). … clinical results have been published for the treatment of lung …
non-small cell lung cancer (NSCLC). … clinical results have been published for the treatment of lung …
MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non–small cell lung carcinoma
J Voortman, A Goto, J Mendiboure, JJ Sohn… - Cancer research, 2010 - AACR
… Adjuvant Lung Cancer Trial (IALT), the largest randomized study conducted to date of
adjuvant chemotherapy in patients with radically resected non–small cell lung carcinoma (NSCLC)…
adjuvant chemotherapy in patients with radically resected non–small cell lung carcinoma (NSCLC)…
[HTML][HTML] Treatment patterns and clinical outcomes among metastatic non–small-cell lung cancer patients treated in the community practice setting
E Nadler, JL Espirito, M Pavilack, M Boyd… - Clinical Lung Cancer, 2018 - Elsevier
… Multiple therapeutic options now exist for metastatic non–small-cell lung cancer (mNSCLC).
In this study we evaluated treatment patterns and outcomes in mNSCLC patients who …
In this study we evaluated treatment patterns and outcomes in mNSCLC patients who …
Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group
S Umemura, K Tsubouchi, H Yoshioka, K Hotta… - Lung Cancer, 2012 - Elsevier
OBJECTIVE: We examined the prognosis of patients with leptomeningeal metastasis (LM)
from non-small cell lung cancer (NSCLC) and that stratified by epidermal growth factor …
from non-small cell lung cancer (NSCLC) and that stratified by epidermal growth factor …
Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer
K Yoh, G Ishii, T Yokose, Y Minegishi, K Tsuta… - Clinical Cancer …, 2004 - AACR
… patients with advanced non-small cell lung cancer, according to breast cancer resistance
protein (… B, the overall survival curves for 72 patients with advanced non-small cell lung cancer, …
protein (… B, the overall survival curves for 72 patients with advanced non-small cell lung cancer, …